scispace - formally typeset
R

Rebecka Arnsrud Godtman

Researcher at Sahlgrenska University Hospital

Publications -  43
Citations -  1061

Rebecka Arnsrud Godtman is an academic researcher from Sahlgrenska University Hospital. The author has contributed to research in topics: Prostate cancer & Medicine. The author has an hindex of 8, co-authored 24 publications receiving 647 citations. Previous affiliations of Rebecka Arnsrud Godtman include University of Gothenburg.

Papers
More filters
Journal ArticleDOI

Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.

TL;DR: A large proportion of men with screen-detected PCa can be managed with AS and appears safe for men with low-risk PCa, according to a competing risk analysis.
Journal ArticleDOI

Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial

TL;DR: Long-term results from this study indicate that some men will miss their chance of cure with active surveillance and it is questionable whether active surveillance is a suitable strategy for men who are not in the lowest tumor risk group and who have a very long remaining life expectancy.
Journal ArticleDOI

Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial.

TL;DR: Organized screening reduces PC mortality but is associated with overdiagnosis, and prostate-specific antigen (PSA) screening within the framework of an organized program seems more effective than unorganized screening.
Journal ArticleDOI

High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm.

TL;DR: This study concludes that Swedish death certificates are of high accuracy and can be used for endpoint evaluation in screening studies for PC.